Qube Research & Technologies (QRT)’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
SCM
RCM
AW
Qube Research & Technologies (QRT)'s BCAT Position: Q2 2024 in Review
Qube Research & Technologies (QRT) sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q2 2024, closing a stake of 84,178 shares — an estimated $1.4M sold.
Qube Research & Technologies (QRT) first reported a position in BCAT in Q4 2022 and held it in 6 quarters. The position peaked at $1.4M in Q1 2024. 86 funds tracked by Wall St. Rank hold BCAT as of Q2 2024.
- Qube Research & Technologies (QRT) reported no remaining BlackRock Capital Allocation Term Trust position as of Q2 2024 after selling out during the quarter.
- Qube Research & Technologies (QRT) sold 84,178 BlackRock Capital Allocation Term Trust shares in Q2 2024, an estimated $1.4M.
- Qube Research & Technologies (QRT) first reported a position in BlackRock Capital Allocation Term Trust in Q4 2022 and held it in 6 quarters.
- Qube Research & Technologies (QRT)'s BlackRock Capital Allocation Term Trust position peaked at $1.4M in Q1 2024.
- 86 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2024.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.